Prof. Jens Damsgaard Mikkelsen has received 435,000 DKK from The Lundbeck Foundation for the project "ASEM as a novel high-affinity radioligand for imaging alpha7 nicotinic acetylcholine receptors: Applicability for imaging with in vitro autoradiography and positron emission tomography (PET)".
Tuesday Oct 11th, "TV2 Nyhederne" ran a story about the Aggression study that has recently been conducted at NRU as part of Sofi da Cunha-Bang's PhD project. Gitte Moos Knudsen was interviewed as part of the story.
Congratulations to PhD student Mette Thrane Foged from NRU for recently winning a poster award at the "12th European Congress on Epileptology" which was held on September 11th-15th in Prague, Czech Republic.
On Friday September 23rd, NRU will be celebrating 20 years anniversary as independent research unit. The celebration will start at 2pm in Auditorium 2 at Rigshospitalet where there will be a 3-hour symposium with talks (in Danish) by current and previous NRU employees. The program for the symposium can be found below.
Gitte Moos Knudsen has recently received a grant worth 1.844 mio DKK from the The Danish Council for Independent Research - Medical Sciences for the project "In vivo assessment of novel pharmacological interventions in humans: An experimental medicine approach evaluating psilocybin and the serotonin 2A receptor". The project has a direct link to WP2 in NeuroPharm.
Congratulations to Cheng Teng Ip who has received an industrial PhD grant from the Innovation Fund Denmark for her project 'EEG and ERP biomarkers for prediction of antidepressant treatment response', which will be carried out together with H. Lundbeck A/S. The company covers 50% of Cheng's salary and she will be employed at the company for three years. The project is tightly connected to the NRU research in NeuroPharm, especially WP1, and Gitte Moos Knudsen will be project supervisor together with Søren Rahn Christensen who is Clinical Pharmacology Scientist at H. Lundbeck A/S.
Congratulations to Gitte Moos Knudsen and Matthias Herth who have been part of a successful proposal for the EU Joint Programme - Neurodegenerative Disease Research (JPND research) entitled "Framework for Innovative Multi-tracer molecular Brain Imaging (IMBI) to enable multi-centre trials and image evaluation in (early) neurodegenerative diseases". The proposal has received 49.900 € in funding for establishing an international working group with key experts from the field of PET imaging in neurodegenerative diseases (ND) with the aims: